Lomedia 24 Fe
Loestrin 24 Fe (Warner Chilcott)
Amneal Pharmaceuticals’ Lomedia 24 Fe is an
AB-rated generic equivalent to Warner Chilcott’s discontinued Loestrin 24 Fe. Lomedia 24 Fe contains norethindrone acetate and ethinyl estradiol 1 mg/20 mcg and ferrous fumarate 75 mg. It is indicated for prevention of pregnancy in women who elect to use oral contraceptives.
Tablets: 1 mg/20 mcg, 75 mg
For More Information: www.amneal.com
Doxycycline Capsules, USP
Monodox Capsules (Aqua Pharmaceuticals LLC)
Lupin Limited has received FDA approval to market doxycycline capsules, USP, 50 mg, 75 mg, and 100 mg, which are the AB-rated generic equivalent to Monodox Capsules, 50 mg, 75 mg, and 100 mg, by Aqua Pharmaceuticals, LLC.. Doxycycline capsules, USP, are indicated for the treatment of infections caused by various microorganisms, and as an adjunctive therapy in severe acne.
Capsules: 50, 75, and 100 mg
For More Information: www.lupinpharmaceuticals.com
XULANE Transdermal System
Mylan Pharmaceuticals, Inc
ORTHO EVRA (Janssen Pharmaceuticals Inc)
Mylan Pharmaceuticals, Inc, has launched XULANE (norelgestromin, ethinyl estradiol transdermal system), the generic version of Janssen Pharmaceuticals, Inc’s, ORTHO EVRA. Mylan received final approval from the FDA for its Abbreviated New Drug Application for this product. This product is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception.
Transdermal patch: 150/35 mcg per day
For More Information: www.mylan.com
Ohm Laboratories, Inc
Ohm Laboratories, Inc, a wholly owned subsidiary of Ranbaxy Laboratories, Limited, announced today that Ohm has received FDA approval to manufacture and market Valsartan 40-, 80-, 160-, and 320-mg tablets on an exclusive basis. Valsartan is the generic version of Novartis’ Diovan. It is indicated for the treatment of high blood pressure and heart failure.
Tablets: 40, 80, 160, and 320 mg
For More Information: www.ranbaxy.com
Fenofibrate Tablets, Fenofibric Acid DR Capsules, Etodolac ER Tablets, Bupropion 300 mg ER Tablets, and Niacin ER Tablets
Since Zydus Pharmaceuticals’ first commercial launch in August 2005, it has grown steadily over the past 9 years and now offers more than 270 SKUs to the US market. Some of Zydus’ recent launches include fenofibrate tablets, fenofibric acid DR capsules, etodolac ER tablets, bupropion 300 mg ER tablets, and niacin ER tablets. Zydus is currently ranked number 8 in the leading corporations of unbranded generics in the US market based on dispensed prescriptions (IMS Health).
For More Information: www.zydususa.com